Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasm Malignant Female 1

Interventions

Specimen Handling 271Magnetic Resonance Spectroscopy 228pembrolizumab 219Carboplatin 180Cisplatin 146Biopsy 143Cyclophosphamide 137Paclitaxel 128Nivolumab 117Gemcitabine 105Bevacizumab 104Radiotherapy 86Dexamethasone 83Pemetrexed 79fludarabine 73Fluorouracil 73Docetaxel 73Doxorubicin 72atezolizumab 71Radiation 71Leucovorin 68Rituximab 65Oxaliplatin 64venetoclax 60Prednisone 59durvalumab 58Cetuximab 56Vincristine 55Etoposide 54Lenalidomide 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Immunophenotyping × 30 days × Clear all
NCT04198727 2026-06-02

DPDMAX

Centre Antoine Lacassagne

Phase 2 Active not recruiting
155 enrolled
Breast

Breast Neoplasm Malignant Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡